At what price level will KAPA find support?

``` The deep research logic is organized as follows: Okay, let's tackle the user's question: "At what price level will KAPA find support?" First, I need to check the provided references for any data related to KAPA's support level. Looking through the references, Number 1 mentions KAPA.A with a support level of $0.5 as of 2025-07-01. That's the key data point here. Next, I should consider the current price of KAPA. The last price listed is $0.7, which is above the support level. The last change is a decrease of 1.27%, so the stock is slightly down. The support level is crucial because it's the price point where the stock might find buying pressure if it continues to drop. I also need to check if there's any other relevant information in the references that could affect KAPA's support. Looking at Number 15, there's a mention of KAPA presenting promising cancer drug data at the ASCO meeting. This could be a positive catalyst, but the support level is a technical analysis point, so the data from Number 1 is more directly relevant. The user's question is straightforward, so the answer should be concise. I'll structure the response by stating the support level first, then provide context about the current price and recent performance. Including the visualization as per the requirements is important, so I'll add the KAPA Support Level tag right after the relevant paragraph. I should also ensure that the answer adheres to the format requirements, using bold text for key points and a table if necessary. Since the data is already in a table in the reference, I can present it clearly without adding extra tables. The conclusion should be clear and directly answer the question, followed by a brief analysis explaining the significance of the support level and the current market context. Finally, I'll make sure to cite the reference correctly using and include the visualization tag immediately after the paragraph that uses the citation. No other references seem relevant to the support level question, so I'll focus solely on the data from Number 1. ``` **Conclusion** 🎯 KAPA (Kairos Pharma) has a defined **support level at $0.5** as of July 1, 2025, based on technical analysis . This level represents a critical price point where the stock may encounter buying pressure if it continues to decline. --- ### 📊 **Analysis of KAPA's Support Level** | Metric | Value | Implication | |------------------------|-------------|------------------------------------------------------------------------------| | **Support Level** | $0.5 | Key price floor; potential reversal point if breached. | | **Last Price** | $0.7 | Currently trading **20% above** the support level. | | **Recent Performance** | -1.27% | Slight downward pressure, but still **above** the critical support zone. | #### Key Takeaways 📝 1. **Technical Context**: The $0.5 support level acts as a **price floor** for KAPA. If the stock dips below this level, it could trigger a short-term bounce or consolidation. 2. **Market Position**: At $0.7, KAPA is **20% above** its support, indicating **near-term stability** but also vulnerability to further downside pressure. 3. **Catalysts**: Recent clinical data updates (e.g., KROS101 cancer drug) could influence sentiment, but the support level remains a **purely technical** anchor . |code|Ticker|Name|Date|Support Level|market_code| |---|---|---|---|---|---| |KAPA|KAPA.A|Kairos Pharma|20250701|0.5022|170|